Share
4,457 Posts.
lightbulb Created with Sketch. 341
clock Created with Sketch. 06/05/20
09:43
Share
Originally posted by bedger:
↑
, by Day 14, 62 percent of patients treated early were able to be discharged from the hospital, compared with 49 percent of patients who were treated late.Gilead's Remdesivir:
Expand
Still trying to my head around all this stuff so excuse my ignorance, but when comparing say MSB against Gilead, or any treatment, wouldn't these trials with relatively small numbers be easily skewed by the underlying non-conforming health of the patients? After all, they're all going to be different in some way, which can increase or decrease their response to treatment and may be the differences in percentage terms. I would imagine they'd take this in to account when assessing efficacy.
(20min delay)